[1]
Muhammad Rehman 2026. Off-label semaglutide: A call for monitoring protocols in non-obese populations. Journal of the Pakistan Medical Association. 76, 8 (Jul. 2026), 1402–1402. DOI:https://doi.org/10.47391/JPMA.33096.